Key result
Multimodal imaging enables timely diagnosis of primary cardiac lymphoma, leading to 1-year complete remission with R-CHOP.
Case Report (n=1)
No
Multimodal imaging is valuable for the timely diagnosis of rare primary cardiac lymphomas.
Answers are grounded in this paper and cite their sources.
May aid rare cardiac mass evaluation; leaves open prospective validation of multimodal imaging in primary cardiac lymphoma.
Primary cardiac lymphoma (PCL) is a rare extranodal lymphoma that involves only the heart and/or pericardium. It is fatal in the absence of a prompt diagnosis and adequate therapy. Here, we report an immunocompetent 55-year-old Chinese man with palpitations and occasional chest distress for 1 month. Multimodal imaging work-up showed a tumor infiltrated into the myocardium, which greatly contribute to a timely pathology diagnosis of PCL.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) conducted a case report in Primary cardiac diffuse large B-cell lymphoma (n=1). Multimodal imaging work-up (TTE, MCE, CMRI, PET/CT) followed by R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) was evaluated on Complete clinical remission at 1 year. Multimodal imaging facilitated timely diagnosis of primary cardiac lymphoma in a 55-year-old man, leading to complete remission at 1 year after 6 cycles of R-CHOP.
Synapse has enriched 10 related papers. Consider them for comparative context: